Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

118.31 +0.55 (+0.47%)
Streaming Delayed Price Updated: 1:59 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
40 41 Next >
Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar?
While analysts look forward to the unfolding reporting season with guarded optimism, they are skeptical regarding forward guidance. 
Via Benzinga
3 Dividend Growth Stocks You Can Buy and Hold Forever
Investors can sit back and let the dividends flow in with these great stocks. 
Via The Motley Fool
Over Delivering: Big Banks Beat Expectations After Tough Quarter, But Market Eyes Middle East Warily
(Friday market open) Big bank earnings this morning threatened to take a back seat as geopolitical worries helped spark a rally in crude oil and sent more investors fleeing toward the perceived safety... 
Via Benzinga
Exposures Fossil Fuels
Abbott Laboratories Unusual Options Activity For October 12
Via Benzinga
Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets
Higher-than-expected inflation data this week caught markets off guard, and the Israel-Hamas conflict is sending the markets running to safer assets. 
Via Benzinga
Topics Economy
Exposures Interest Rates
As Isreal-Palestine Conflict Escalates, Gold Ticks Up - ETF Winners And Losers: Medium-Cap Returns
Via Benzinga
Topics ETFs
Why Medtronic And Abbott Stocks Are Sinking
Medtronic plc. (NYSE: MDT) and Abbott Laboratories (NYSE: ABT) shares are trading lower on Wednesday after the U.S. 
Via Benzinga
3 Reasons to Buy Abbott Laboratories Stock
Don't just focus on the recent past. 
Via The Motley Fool
Looking Into Abbott Laboratories's Recent Short Interest
Via Benzinga
If You Invested $1000 In This Stock 10 Years Ago, You Would Have $2,900 Today
Via Benzinga
Abbott Laboratories Explores Consumer Wearables Market As COVID Testing Sales Dwindle: CEO
Abbott Laboratories (NYSE: ABT) CEO Robert Ford, while speaking at the HLTH conference in Las Vegas, outlined the company's strategic move into the consumer wearables market.  
Via Benzinga
Exposures COVID-19
Jim Carmer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Abbott Laboratories (NYSE: ABT) is a "very good company and will be up to the—let’s say—up to the challenge. I think that’s fair. 
Via Benzinga
3 Dividend Kings Every Investor Should Own to Survive a Market Crash
Dividend stocks that raise their payout beat all other kinds of stocks, making Dividend Kings the best stocks to buy in a downturn. 
Via InvestorPlace
Lumentum Lights Up on the AI and ML Surge
Optical and photonics manufacturer Lumentum Holdings Inc. (NASDAQ: LITE) provides optical components and lasers to data centers, cloud providers, telecoms 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Abbott Laboratories Unusual Options Activity
Via Benzinga
Looking At Abbott Laboratories's Recent Unusual Options Activity
Via Benzinga
Abbott Stock: Bear vs. Bull
Abbott is a favorite of income-oriented investors, but is the price right? 
Via The Motley Fool
2 Magnificent Dividend Stocks to Buy Hand Over Fist in October
These two healthcare stocks are reliable passive income vehicles. 
Via The Motley Fool
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
These companies are helping change medicine; they could make boatloads of money along the way. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Abbott Laboratories And More On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management named Innovator U.S. 
Via Benzinga
Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years
A basket of passive income opportunities in oil and gas, renewable energy, and healthcare. 
Via The Motley Fool
P/E Ratio Insights for Abbott Laboratories
Via Benzinga
This Is What Whales Are Betting On Abbott Laboratories
Via Benzinga
(ABT) - Analyzing Abbott Laboratories's Short Interest
Via Benzinga
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle
Abbott and Dexcom stocks have tumbled as GLP-1 drugs have gripped the nation. 
Via Investor's Business Daily
2 Stocks to Benefit from the Aging Population
The growth of the aging population is entirely predictable, which makes now an ideal time to consider these two health and wellness stocks 
Via MarketBeat
Topics Retirement
Exposures COVID-19 Pension
3 Best Stocks to Buy in September and Hold Forever
Healthcare blue chip stocks with proven track records can be excellent long-term investments. 
Via The Motley Fool
3 Unstoppable Nasdaq 100 Stocks Just Waiting to Be Bought
Tech stocks were the primary fuel for a decades-long bull market, and these three Nasdaq stocks to buy can lead the market forward. 
Via InvestorPlace
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
40 41 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.